WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

South Korea · Delayed Price · Currency is KRW

6,480.00

-220.00 (-3.28%)

At close: Nov 13, 2026

Market Cap	85.53B -2.1%
Revenue (ttm)	111.72B +9.0%
Net Income	7.96B +33.2%
EPS	603.28 +33.1%
Shares Out	13.20M
PE Ratio	10.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,166
Open	6,690.00
Previous Close	6,700.00
Day's Range	6,450.00 - 6,700.00
52-Week Range	5,910.00 - 11,950.00
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About KOSDAQ:330350

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co., Ltd. and changed its name ... [Read more]

Industry Pharmaceutical Preparations

Founded 2004

Employees 121

Stock Exchange KOSDAQ

Ticker Symbol 330350

Full Company Profile

Financial Performance

In 2025, KOSDAQ:330350's revenue was 106.44 billion, an increase of 3.62% compared to the previous year's 102.72 billion. Earnings were 4.97 billion, an increase of 3.81%.

Financial Statements